The portfolio maintains a cost advantage over competitors, priced within the second-lowest fee quintile among peers.
Impax International Sust Econ Inv PXINX
- NAV / 1-Day Return 11.75 / −0.93 %
- Total Assets 1.3 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.700%
- Distribution Fee Level Below Average
- Share Class Type No Load
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 2.11%
- Turnover 56%
USD | NAV as of Sep 27, 2024 | 1-Day Return as of Sep 27, 2024, 10:20 PM GMT+0
Morningstar’s Analysis PXINX
Will PXINX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 23.4
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novo Nordisk A/S Class B | 3.05 | 37.6 Mil | Healthcare |
Novartis AG Registered Shares | 2.69 | 33.2 Mil | Healthcare |
AstraZeneca PLC | 2.66 | 32.8 Mil | Healthcare |
ASML Holding NV | 2.64 | 32.6 Mil | Technology |
HSBC Holdings PLC | 2.40 | 29.6 Mil | Financial Services |
Schneider Electric SE | 2.19 | 27.0 Mil | Industrials |
CSL Ltd | 2.03 | 25.1 Mil | Healthcare |
BNP Paribas Act. Cat.A | 1.98 | 24.4 Mil | Financial Services |
RELX PLC | 1.89 | 23.3 Mil | Industrials |
KDDI Corp | 1.89 | 23.3 Mil | Communication Services |